| answer text |
<p>The Government is committed to making the United Kingdom a leader in embedding
genomics in healthcare and offer a consistent, world class approach to the genetic
identification of rare diseases, including genetic hemochromatosis. The Genomics Medicine
Service was announced in October 2018, supported by the National Genomic Test Directory
which specifies which genomic tests are commissioned by the National Health Service
in England, the technology by which they are available, and the patients who will
be eligible to access a test. Genetic haemochromatosis is included in the National
Genomic Test Directory.</p><p>Services for patients with genetic haemochromatosis
are commissioned locally through clinical commissioning groups with sustainability
and transformation partnerships (STPs) enabling service coordination across wider
footprints. The NHS Long Term Plan set out the ambition for all STPs to evolve into
Integrated Care Systems (ICSs) by April 2021. ICSs are an ‘evolved’ form of an STP,
making faster progress in integrating care across their area, bringing together organisations
to provide more seamless care for patients.</p>
|
|
